Electronic healthcare databases for active drug safety surveillance: is there enough leverage?-Reference-Cited by-同舟云学术

Electronic healthcare databases for active drug safety surveillance: is there enough leverage?

Published:2012-02-08 Issue:6 Volume:21 Page:611-621
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidemiol Drug Saf

Author:

Coloma Preciosa M.¹,Trifirò Gianluca¹²,Schuemie Martijn J.¹,Gini Rosa³,Herings Ron⁴,Hippisley-Cox Julia⁵,Mazzaglia Giampiero⁶,Picelli Gino⁷,Corrao Giovanni⁸,Pedersen Lars⁹,van der Lei Johan¹,Sturkenboom Miriam¹¹⁰,

Affiliation:

1. Department of Medical Informatics; Erasmus Medical Center; Rotterdam The Netherlands

2. Department of Clinical and Experimental Medicine and Pharmacology, Section of Pharmacology; University of Messina; Messina Italy

3. Agenzia Regionale di Sanità della Toscana; Florence Italy

4. PHARMO Institute; Utrecht The Netherlands

5. Division of Primary Care, School of Community Health Sciences; University of Nottingham; UK

6. Società Italiana di Medicina Generale; Florence Italy

7. Pedianet-Società Servizi Telematici SRL; Padova Italy

8. Department of Statistics; Università di Milano-Bicocca; Milan Italy

9. Department of Clinical Epidemiology; Aarhus University Hospital; Aarhus Denmark

10. Department of Epidemiology; Erasmus Medical Center; Rotterdam The Netherlands

Funder

European Commission Seventh Framework Programme

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pds.3197/fullpdf

Reference48 articles.

1. Limitations and strengths of spontaneous reports data;Goldman;Clin Ther,1998

2. Data mining for signals in spontaneous reporting databases: proceed with caution;Stephenson;Pharmacoepidemiol Drug Saf,2007

3. Improving reporting of adverse drug reactions: systematic review;Molokhia;Clin Epidemiol,2009

4. The Future of Drug Safety: Promoting and Protecting the Health of the Public National Academies Press Washington, DC 2007 http://www.nap.edu

5. What have we learnt from Vioxx?;Krumholz;BMJ,2007

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Active surveillance pharmacovigilance for Clostridioides difficile infection and gastrointestinal bleeding: an analytic framework based on case-control studies;eBioMedicine;2024-05

2. OHDSI Standardized Vocabularies—a large-scale centralized reference ontology for international data harmonization;Journal of the American Medical Informatics Association;2024-01-04

3. Supporting Pharmacovigilance Signal Validation and Prioritization with Analyses of Routinely Collected Health Data: Lessons Learned from an EHDEN Network Study;Drug Safety;2023-10-07

4. Monitoring the appropriate prescription of low molecular weight heparins and Fondaparinux through administrative data. A retrospective observational study in the Tuscany region;PLOS ONE;2023-09-14

5. Methods for drug safety signal detection using routinely collected observational electronic health care data: a systematic review;Real-World Data & Evidence;2023-08-28